Hepatocellular carcinoma (HCC) is the fifth most common cancer globally and the fourth
most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection …

Percutaneous treatment of hepatocellular carcinoma (HCC) encompasses a vast range of
techniques, including monopolar radiofrequency ablation (RFA), multibipolar RFA …

Image-guided tumor ablation has become a well-established hallmark of local cancer
therapy. The breadth of options available in this growing field increases the need for …

Hepatocelluar carcinoma (HCC) is the most common primary malignancy of the liver in
adults and the third most common cause of cancer death worldwide. The incidence of HCC …

Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and the fourth
most common cancer among men in South Korea, where the prevalence of chronic hepatitis …

Hepatocellular carcinoma (HCC) is the fifth most common cancer globally and the fourth
most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection …

Background & Aims Although ultrasonography (US) guided radiofrequency ablation (RFA) is
a commonly used treatment option for early hepatocellular carcinoma (HCC), inconspicuous …

2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular
Carcinoma Login to Submission Gut and Liver 2021 Impact Factor 4.321 Indexed In …

Percutaneous radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC) was
introduced in Japan in 1999. It has been established as a main local treatment method …

Radiofrequency ablation (RFA) is an alternative therapy for hepatocellular carcinoma and
liver metastases when resection cannot be performed or, in the case of hepatocellular …